These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 2024235

  • 1. Heparin cofactor II deficiency in renal allograft recipients: no correlation with the development of thrombosis.
    Toulon P, Moulonguet-Doleris L, Costa JM, Aiach M.
    Thromb Haemost; 1991 Jan 23; 65(1):20-4. PubMed ID: 2024235
    [Abstract] [Full Text] [Related]

  • 2. Plasma and urinary heparin cofactor II levels in patients with nephrotic syndrome.
    Grau E, Oliver A, Félez J, Barceló P, Fernandez C, Ballarin JA, Fontcuberta J, Rutllant ML.
    Thromb Haemost; 1988 Oct 31; 60(2):137-40. PubMed ID: 3217913
    [Abstract] [Full Text] [Related]

  • 3. Increased heparin cofactor II levels in women taking oral contraceptives.
    Toulon P, Bardin JM, Blumenfeld N.
    Thromb Haemost; 1990 Nov 30; 64(3):365-8. PubMed ID: 2096488
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of heparin cofactor II deficiency in patients with a history of venous thrombosis.
    Lopaciuk S, Bykowska K, Kopeć M.
    Pol J Pharmacol; 1996 Nov 30; 48(1):109-11. PubMed ID: 9112638
    [Abstract] [Full Text] [Related]

  • 5. Hereditary heparin cofactor II deficiency and the risk of development of thrombosis.
    Bertina RM, van der Linden IK, Engesser L, Muller HP, Brommer EJ.
    Thromb Haemost; 1987 Apr 07; 57(2):196-200. PubMed ID: 3603411
    [Abstract] [Full Text] [Related]

  • 6. Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis.
    Toulon P, Jacquot C, Capron L, Frydman MO, Vignon D, Aiach M.
    Thromb Haemost; 1987 Jun 03; 57(3):263-8. PubMed ID: 3660328
    [Abstract] [Full Text] [Related]

  • 7. Laboratory determination of heparin cofactor II.
    Ezenagu LC, Brandt JT.
    Arch Pathol Lab Med; 1986 Dec 03; 110(12):1149-51. PubMed ID: 3778142
    [Abstract] [Full Text] [Related]

  • 8. [Activities of antithrombin III and heparin cofactor II in patients with pathologic blood coagulation conditions].
    Hirokawa S, Kaji T, Tazawa K, Fujimaki M, Hayashi T, Niiya K, Sakuragawa N.
    Rinsho Ketsueki; 1992 Mar 03; 33(3):281-7. PubMed ID: 1578630
    [Abstract] [Full Text] [Related]

  • 9. Methodology and clinical significance of heparin cofactor II. Probable heparin cofactor II deficiency in a patient with cerebrovascular thrombosis.
    Tran TH, Zbinden B, Lämmle B, Duckert F.
    Semin Thromb Hemost; 1985 Oct 03; 11(4):342-6. PubMed ID: 3840916
    [Abstract] [Full Text] [Related]

  • 10. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
    Okajima K, Ueyama H, Hashimoto Y, Sasaki Y, Matsumoto K, Okabe H, Inoue M, Araki S, Takatsuki K.
    Thromb Haemost; 1989 Feb 28; 61(1):20-4. PubMed ID: 2749590
    [Abstract] [Full Text] [Related]

  • 11. [Effect of heparin cofactor II on the antithrombin III activities measured by thrombin methods or factor Xa methods--fundamental studies and clinical studies using the plasma of pregnant women].
    Akai Y, Shiga S, Tohyama K, Shimatsu A, Ichiyama S.
    Rinsho Byori; 2000 Sep 28; 48(9):867-71. PubMed ID: 11051806
    [Abstract] [Full Text] [Related]

  • 12. Heparin cofactor II: an acute phase reactant in patients with deep vein thrombosis.
    Toulon P, Vitoux JF, Fiessinger JN, Sicard D, Aiach M.
    Blood Coagul Fibrinolysis; 1991 Jun 28; 2(3):435-9. PubMed ID: 1718466
    [Abstract] [Full Text] [Related]

  • 13. Hereditary heparin cofactor II deficiency and thrombosis: report of six patients belonging to two separate kindreds.
    Simioni P, Lazzaro AR, Coser E, Salmistraro G, Girolami A.
    Blood Coagul Fibrinolysis; 1990 Oct 28; 1(4-5):351-6. PubMed ID: 2133211
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L, Dewar L, Song Y, Kulczycky M, Blajchman MA, Fenton JW, Andrew M, Delorme M, Ginsberg J, Preissner KT.
    Thromb Haemost; 1995 Mar 28; 73(3):405-12. PubMed ID: 7545318
    [Abstract] [Full Text] [Related]

  • 15. Risk factors for early hemorrhagic and thrombotic complications after kidney transplantation.
    Pawlicki J, Cierpka L, Król R, Ziaja J.
    Transplant Proc; 2011 Oct 28; 43(8):3013-7. PubMed ID: 21996213
    [Abstract] [Full Text] [Related]

  • 16. Heparin cofactor II levels are increased by the use of combined oral contraceptives.
    Mackie IJ, Segal H, Burren T, Gallimore M, Walshe KJ, Robinson G, Machin SJ.
    Blood Coagul Fibrinolysis; 1990 Dec 28; 1(6):647-51. PubMed ID: 2133244
    [Abstract] [Full Text] [Related]

  • 17. [Heparin cofactor II and thrombophilic conditions].
    Hudecek J, Hal'áková E, Ivanková J, Kubisz P.
    Vnitr Lek; 1997 May 28; 43(5):317-9. PubMed ID: 9601856
    [Abstract] [Full Text] [Related]

  • 18. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition.
    Demers C, Henderson P, Blajchman MA, Wells MJ, Mitchell L, Johnston M, Ofosu FA, Fernandez-Rachubinski F, Andrew M, Hirsh J.
    Thromb Haemost; 1993 Mar 01; 69(3):231-5. PubMed ID: 8470046
    [Abstract] [Full Text] [Related]

  • 19. Hereditary homozygous heparin cofactor II deficiency and the risk of developing venous thrombosis.
    Villa P, Aznar J, Vaya A, España F, Ferrando F, Mira Y, Estellés A.
    Thromb Haemost; 1999 Sep 01; 82(3):1011-4. PubMed ID: 10494755
    [Abstract] [Full Text] [Related]

  • 20. Comparative turn-over of heparin cofactor II and antithrombin III in baboons. Influence of heparin and pentosan polysulfate administration.
    Sié P, Lansen J, Lacheretz F, Verschuere B, Boneu B.
    Thromb Haemost; 1986 Dec 15; 56(3):302-7. PubMed ID: 2436331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.